COM:PROVENTIONBIO

Sanofi

Stock

Last Close

24.98

26/04 20:00

Market Cap

2.38B

Beta: -

Volume Today

9.12M

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22
net income	-9.13M -	-26.48M 189.91%	-43.28M 63.48%	-98.58M 127.75%	-114.43M 16.08%	-113.56M 0.76%
depreciation and amortization			-16K -	33K 306.25%	387K 1,072.73%	1.23M 217.31%
deferred income tax			16K -	247K 1,443.75%	538K 117.81%
stock based compensation	206.72K -	1.14M 451.95%	2.84M 149.08%	13.22M 365.27%	11.84M 10.47%	19.03M 60.72%
change in working capital	519.86K -	-1.80M 446.83%	4.39M 343.70%	8.72M 98.38%	6.32M 27.50%	17.94M 183.81%
accounts receivables						-1.36M -
inventory						-1.23M -
accounts payables	459.75K -	109K 76.29%	1.21M 1,007.34%	5.79M 379.95%	-4.02M 169.43%	3.21M 179.94%
other working capital	60.11K -	-1.91M 3,280.89%	3.19M 266.68%	2.92M 8.25%	10.34M 253.69%	17.31M 67.40%
other non cash items	3.52M -	4.50M 27.60%	-16K 100.36%	25K 256.25%	-37K 248%	-36K 2.70%
net cash provided by operating activities	-4.88M -	-22.64M 363.81%	-36.06M 59.28%	-76.34M 111.66%	-95.39M 24.95%	-75.41M 20.94%
investments in property plant and equipment				-1.11M -	-961K 13.50%	-795K 17.27%
acquisitions net
purchases of investments			-46.25M -	-28.71M 37.91%	-55.28M 92.53%	-103.08M 86.46%
sales maturities of investments				55M -	25.15M 54.27%	30.75M 22.27%
other investing activites						-15M -
net cash used for investing activites			-46.25M -	25.17M 154.43%	-31.10M 223.52%	-88.13M 183.40%
debt repayment
common stock issued	1K -	59.35M 5,934,600%	62.94M 6.06%	113.14M 79.75%	102.33M 9.55%	104.64M 2.26%
common stock repurchased
dividends paid
other financing activites	26.71M -			1.15M -	48K 95.83%	24.75M 51,452.08%
net cash used provided by financing activities	26.72M -	59.35M 122.14%	62.94M 6.06%	114.29M 81.58%	102.38M 10.42%	129.38M 26.38%
effect of forex changes on cash
net change in cash	21.83M -	36.70M 68.11%	-19.37M 152.78%	63.13M 425.84%	-24.10M 138.18%	-34.15M 41.68%
cash at beginning of period		21.83M -	58.54M 168.11%	39.16M 33.10%	102.29M 161.19%	78.19M 23.56%
cash at end of period	21.83M -	58.54M 168.11%	39.16M 33.10%	102.29M 161.19%	78.19M 23.56%	44.04M 43.68%
operating cash flow	-4.88M -	-22.64M 363.81%	-36.06M 59.28%	-76.34M 111.66%	-95.39M 24.95%	-75.41M 20.94%
capital expenditure				-1.11M -	-961K 13.50%	-795K 17.27%
free cash flow	-4.88M -	-22.64M 363.81%	-36.06M 59.28%	-77.45M 114.74%	-96.35M 24.40%	-76.20M 20.91%

All numbers in (except ratios and percentages)